![]() |
市場調查報告書
商品編碼
1926499
如何在營養保健品產業中駕馭女性健康成分市場Navigating the Women's Health Ingredients Market in the Nutraceutical Industry |
||||||
產業對女性健康的日益關注推動了變革性成長
儘管女性健康領域已成為整個健康產業中成長最快的細分市場之一,但仍面臨許多挑戰。長期以來,女性在臨床試驗中的參與度一直偏低,導致缺乏針對女性健康狀況的特定數據。由於許多營養保健品和藥品主要針對男性進行研究,因此人們對這些產品如何對女性產生不同影響缺乏了解,從而導致誤診、治療無效和副作用。根據世界經濟論壇發布的《2024年消除女性健康差距》報告,在美國,女性服用已獲已通過核准藥物後出現不利事件的機率比男性高52%,嚴重或致命不良反應的機率高36%。報告也指出,女性經歷健康狀況不佳的年資比男性多25%。該行業面臨的挑戰在於,如何透過開發對女性安全有效的產品來消除這種差距,尤其是在生殖健康、荷爾蒙平衡和更年期骨骼健康等領域。
《全球女性健康營養保健品成分市場》研究報告聚焦在女性在各個生命階段(從青春期、生育期到更年期後)的特定營養需求。該市場蘊藏著豐富的機遇,預計在預測期(2025-2031年)內將維持強勁成長。
Increasing Industry Focus on Women's Health Driving Transformational Growth
The women's health space is emerging as one of the fastest-growing segments within the broader health and wellness industry; however, certain challenges persist. Historically, women have been underrepresented in clinical trials, leading to a lack of data specifically focused on female health conditions. Most nutraceutical and pharmaceutical products have been primarily studied in men only, resulting in an insufficient understanding of how these products affect women differently, leading to misdiagnoses, ineffective treatments, and adverse effects. As per the World Economic Forum's "Closing the Women's Health Gap 2024" report, US women have 52% more adverse events and 36% more serious or fatal events from approved medicines than men. Also, the report mentions that women spend 25% more of their lives in poor health than men. The industry's challenge is to close this gap by developing products that are safe and effective for women, particularly in areas such as reproductive health, hormonal balance, and menopause induced bone health.
This Global Women's Health Nutraceutical Ingredients Market study focuses on addressing the specific nutritional needs of women across different stages of life, from adolescence through the childbearing years to menopause and beyond. The market is ripe with opportunities, with projected strong growth during the forecast period (2025-2031).